SLNO
Soleno Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Headquartered in Redwood City, California, the company aims to bring therapies for life-threatening genetic disorders to patients and families worldwide. Its efforts emphasize translating promising research into clinically meaningful treatments for underserved rare-disease populations.